AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PureTech Health plc

Transaction in Own Shares Jun 6, 2023

4932_rns_2023-06-06_43b45241-ae4e-4af0-a32a-15dd5343c75a.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7179B

PureTech Health PLC

06 June 2023

6 June 2023

PureTech Health plc

Transaction in Own Shares

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

Date of purchase: 5 June 2023
Number of ordinary shares purchased: 17,052
Highest price paid per share: 234.50p
Lowest price paid per share: 232.50p
Volume weighted average price paid per share: 234.45p

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 11,963,789 ordinary shares in treasury and has 277,504,370 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 277,504,370 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both US FDA clearance and European marketing authorization and a third (KarXT) that is expected to be filed soon for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.

Contact:

PureTech

Investor Relations

[email protected]

Individual Transactions

Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
05/06/2023 16:07:20 38 234.5 CHIX 00355359348TRLO1.1.1
05/06/2023 16:07:20 42 234.5 CHIX 00355359346TRLO1.1.1
05/06/2023 16:07:20 56 234.5 CHIX 00355359347TRLO1.1.1
05/06/2023 16:07:20 51 234.5 CHIX 00355359344TRLO1.1.1
05/06/2023 16:07:20 154 234.5 CHIX 00355359345TRLO1.1.1
05/06/2023 16:06:20 17 234.5 TRQX 00355358773TRLO1.1.1
05/06/2023 16:06:20 14 234.5 TRQX 00355358772TRLO1.1.1
05/06/2023 16:06:20 536 234.5 TRQX 00355358771TRLO1.1.1
05/06/2023 16:06:20 13 234.5 TRQX 00355358769TRLO1.1.1
05/06/2023 16:06:20 13 234.5 TRQX 00355358770TRLO1.1.1
05/06/2023 16:06:20 13 234.5 TRQX 00355358767TRLO1.1.1
05/06/2023 16:06:20 13 234.5 TRQX 00355358768TRLO1.1.1
05/06/2023 16:06:20 13 234.5 TRQX 00355358765TRLO1.1.1
05/06/2023 16:06:20 13 234.5 TRQX 00355358766TRLO1.1.1
05/06/2023 16:06:20 16 234.5 TRQX 00355358763TRLO1.1.1
05/06/2023 16:06:20 17 234.5 TRQX 00355358762TRLO1.1.1
05/06/2023 16:06:20 15 234.5 TRQX 00355358764TRLO1.1.1
05/06/2023 16:06:20 19 234.5 TRQX 00355358761TRLO1.1.1
05/06/2023 16:06:20 10 234.5 TRQX 00355358760TRLO1.1.1
05/06/2023 16:06:20 11 234.5 TRQX 00355358758TRLO1.1.1
05/06/2023 16:06:20 12 234.5 TRQX 00355358759TRLO1.1.1
05/06/2023 16:06:20 13 234.5 TRQX 00355358757TRLO1.1.1
05/06/2023 16:06:20 13 234.5 TRQX 00355358755TRLO1.1.1
05/06/2023 16:06:20 13 234.5 TRQX 00355358756TRLO1.1.1
05/06/2023 16:06:20 11 234.5 TRQX 00355358754TRLO1.1.1
05/06/2023 16:06:20 12 234.5 TRQX 00355358753TRLO1.1.1
05/06/2023 16:06:20 16 234.5 TRQX 00355358752TRLO1.1.1
05/06/2023 16:06:20 52 234.5 TRQX 00355358751TRLO1.1.1
05/06/2023 16:06:20 190 234.5 XLON 00355358750TRLO1.1.1
05/06/2023 16:06:20 181 234.5 XLON 00355358749TRLO1.1.1
05/06/2023 16:06:20 7 234.5 TRQX 00355358748TRLO1.1.1
05/06/2023 16:06:20 13 234.5 TRQX 00355358747TRLO1.1.1
05/06/2023 16:06:20 611 234.5 XLON 00355358746TRLO1.1.1
05/06/2023 16:06:20 232 234.5 XLON 00355358745TRLO1.1.1
05/06/2023 16:06:19 9 234.5 AQXE 00355358740TRLO1.1.1
05/06/2023 16:06:19 24 234.5 AQXE 00355358739TRLO1.1.1
05/06/2023 16:06:19 101 234.5 AQXE 00355358738TRLO1.1.1
05/06/2023 16:06:19 21 234.5 AQXE 00355358737TRLO1.1.1
05/06/2023 16:06:19 23 234.5 AQXE 00355358736TRLO1.1.1
05/06/2023 16:06:19 66 234.5 AQXE 00355358735TRLO1.1.1
05/06/2023 16:06:19 23 234.5 AQXE 00355358734TRLO1.1.1
05/06/2023 16:06:19 23 234.5 AQXE 00355358733TRLO1.1.1
05/06/2023 16:06:19 29 234.5 AQXE 00355358732TRLO1.1.1
05/06/2023 16:06:19 43 234.5 AQXE 00355358730TRLO1.1.1
05/06/2023 16:06:19 22 234.5 AQXE 00355358731TRLO1.1.1
05/06/2023 16:06:19 30 234.5 AQXE 00355358729TRLO1.1.1
05/06/2023 16:06:19 24 234.5 AQXE 00355358728TRLO1.1.1
05/06/2023 16:06:19 24 234.5 AQXE 00355358727TRLO1.1.1
05/06/2023 16:06:19 16 234.5 AQXE 00355358726TRLO1.1.1
05/06/2023 16:06:19 23 234.5 AQXE 00355358724TRLO1.1.1
05/06/2023 16:06:19 30 234.5 AQXE 00355358723TRLO1.1.1
05/06/2023 16:06:19 22 234.5 AQXE 00355358725TRLO1.1.1
05/06/2023 16:06:19 22 234.5 AQXE 00355358722TRLO1.1.1
05/06/2023 16:06:19 28 234.5 AQXE 00355358721TRLO1.1.1
05/06/2023 16:06:19 22 234.5 AQXE 00355358720TRLO1.1.1
05/06/2023 16:06:19 24 234.5 AQXE 00355358719TRLO1.1.1
05/06/2023 16:06:19 22 234.5 AQXE 00355358718TRLO1.1.1
05/06/2023 15:27:29 10 234.5 XLON 00355341115TRLO1.1.1
05/06/2023 15:26:34 500 234.5 XLON 00355340750TRLO1.1.1
05/06/2023 15:26:34 107 234.5 XLON 00355340749TRLO1.1.1
05/06/2023 15:26:34 145 234.5 XLON 00355340748TRLO1.1.1
05/06/2023 15:26:34 52 234.5 BATE 00355340746TRLO1.1.1
05/06/2023 15:26:34 60 234.5 BATE 00355340747TRLO1.1.1
05/06/2023 15:26:34 66 234.5 BATE 00355340745TRLO1.1.1
05/06/2023 15:26:34 69 234.5 BATE 00355340744TRLO1.1.1
05/06/2023 15:26:34 22 234.5 BATE 00355340743TRLO1.1.1
05/06/2023 15:26:34 3 234.5 CHIX 00355340742TRLO1.1.1
05/06/2023 15:26:34 45 234.5 CHIX 00355340741TRLO1.1.1
05/06/2023 15:26:34 30 234.5 CHIX 00355340740TRLO1.1.1
05/06/2023 15:26:34 14 234.5 CHIX 00355340739TRLO1.1.1
05/06/2023 15:26:34 52 234.5 CHIX 00355340738TRLO1.1.1
05/06/2023 15:26:34 47 234.5 CHIX 00355340737TRLO1.1.1
05/06/2023 15:26:34 47 234.5 CHIX 00355340736TRLO1.1.1
05/06/2023 15:26:34 36 234.5 CHIX 00355340735TRLO1.1.1
05/06/2023 15:26:34 179 234.5 XLON 00355340734TRLO1.1.1
05/06/2023 15:26:34 51 234.5 BATE 00355340731TRLO1.1.1
05/06/2023 15:26:34 306 234.5 XLON 00355340733TRLO1.1.1
05/06/2023 15:26:34 41 234.5 BATE 00355340732TRLO1.1.1
05/06/2023 15:26:34 43 234.5 BATE 00355340730TRLO1.1.1
05/06/2023 15:26:34 61 234.5 BATE 00355340728TRLO1.1.1
05/06/2023 15:26:34 62 234.5 BATE 00355340729TRLO1.1.1
05/06/2023 15:26:34 272 234.5 BATE 00355340727TRLO1.1.1
05/06/2023 15:26:34 50 234.5 BATE 00355340725TRLO1.1.1
05/06/2023 15:26:34 65 234.5 BATE 00355340726TRLO1.1.1
05/06/2023 15:26:34 58 234.5 BATE 00355340724TRLO1.1.1
05/06/2023 15:26:34 61 234.5 BATE 00355340722TRLO1.1.1
05/06/2023 15:26:34 45 234.5 BATE 00355340723TRLO1.1.1
05/06/2023 15:26:34 104 234.5 BATE 00355340721TRLO1.1.1
05/06/2023 15:26:34 168 234.5 BATE 00355340720TRLO1.1.1
05/06/2023 15:26:34 619 234.5 BATE 00355340719TRLO1.1.1
05/06/2023 15:26:34 190 234.5 XLON 00355340717TRLO1.1.1
05/06/2023 15:26:34 19 234.5 XLON 00355340716TRLO1.1.1
05/06/2023 15:26:34 44 234.5 CHIX 00355340715TRLO1.1.1
05/06/2023 15:26:34 42 234.5 CHIX 00355340714TRLO1.1.1
05/06/2023 15:26:34 45 234.5 CHIX 00355340713TRLO1.1.1
05/06/2023 15:26:34 50 234.5 CHIX 00355340712TRLO1.1.1
05/06/2023 15:26:34 45 234.5 CHIX 00355340711TRLO1.1.1
05/06/2023 15:26:34 39 234.5 CHIX 00355340710TRLO1.1.1
05/06/2023 15:26:34 41 234.5 CHIX 00355340709TRLO1.1.1
05/06/2023 15:26:34 47 234.5 CHIX 00355340708TRLO1.1.1
05/06/2023 15:26:34 41 234.5 CHIX 00355340707TRLO1.1.1
05/06/2023 15:26:34 181 234.5 CHIX 00355340706TRLO1.1.1
05/06/2023 15:26:34 108 234.5 CHIX 00355340705TRLO1.1.1
05/06/2023 15:26:34 38 234.5 CHIX 00355340704TRLO1.1.1
05/06/2023 15:26:34 428 234.5 CHIX 00355340702TRLO1.1.1
05/06/2023 15:26:34 52 234.5 CHIX 00355340703TRLO1.1.1
05/06/2023 15:26:34 37 234.5 CHIX 00355340701TRLO1.1.1
05/06/2023 15:26:34 40 234.5 CHIX 00355340700TRLO1.1.1
05/06/2023 15:26:34 236 234.5 XLON 00355340699TRLO1.1.1
05/06/2023 15:26:34 472 234.5 XLON 00355340698TRLO1.1.1
05/06/2023 15:26:34 862 234.5 XLON 00355340697TRLO1.1.1
05/06/2023 15:26:34 2346 234.5 XLON 00355340696TRLO1.1.1
05/06/2023 15:26:34 82 234.5 BATE 00355340695TRLO1.1.1
05/06/2023 15:26:34 52 234.5 BATE 00355340694TRLO1.1.1
05/06/2023 15:26:34 57 234.5 BATE 00355340693TRLO1.1.1
05/06/2023 15:26:34 94 234.5 BATE 00355340692TRLO1.1.1
05/06/2023 15:26:34 90 234.5 BATE 00355340691TRLO1.1.1
05/06/2023 15:26:34 6 234.5 TRQX 00355340690TRLO1.1.1
05/06/2023 15:26:34 11 234.5 TRQX 00355340689TRLO1.1.1
05/06/2023 15:26:34 3 234.5 TRQX 00355340688TRLO1.1.1
05/06/2023 15:26:34 194 234.5 XLON 00355340686TRLO1.1.1
05/06/2023 15:26:34 11 234.5 TRQX 00355340687TRLO1.1.1
05/06/2023 15:26:34 228 234.5 XLON 00355340684TRLO1.1.1
05/06/2023 15:26:34 244 234.5 XLON 00355340685TRLO1.1.1
05/06/2023 15:26:34 1033 234.5 XLON 00355340683TRLO1.1.1
05/06/2023 15:26:34 332 234.5 XLON 00355340682TRLO1.1.1
05/06/2023 15:26:34 8 234.5 TRQX 00355340681TRLO1.1.1
05/06/2023 15:26:34 14 234.5 TRQX 00355340680TRLO1.1.1
05/06/2023 15:26:34 18 234.5 TRQX 00355340678TRLO1.1.1
05/06/2023 15:26:34 18 234.5 TRQX 00355340679TRLO1.1.1
05/06/2023 15:26:34 12 234.5 TRQX 00355340677TRLO1.1.1
05/06/2023 15:26:34 12 234.5 TRQX 00355340676TRLO1.1.1
05/06/2023 15:26:34 150 234.5 XLON 00355340675TRLO1.1.1
05/06/2023 15:26:34 328 234.5 XLON 00355340674TRLO1.1.1
05/06/2023 15:26:34 271 234.5 XLON 00355340673TRLO1.1.1
05/06/2023 15:26:34 16 234.5 XLON 00355340671TRLO1.1.1
05/06/2023 15:26:34 206 234.5 XLON 00355340672TRLO1.1.1
05/06/2023 15:26:34 157 234.5 XLON 00355340670TRLO1.1.1
05/06/2023 15:26:34 254 234.5 XLON 00355340669TRLO1.1.1
05/06/2023 15:26:34 10 234.5 TRQX 00355340668TRLO1.1.1
05/06/2023 15:26:34 13 234.5 TRQX 00355340667TRLO1.1.1
05/06/2023 15:26:34 13 234.5 TRQX 00355340666TRLO1.1.1
05/06/2023 15:26:34 208 234.5 XLON 00355340664TRLO1.1.1
05/06/2023 15:26:34 372 234.5 XLON 00355340665TRLO1.1.1
05/06/2023 08:14:25 21 233 AQXE 00355211754TRLO1.1.1
05/06/2023 08:09:23 47 232.5 CHIX 00355210856TRLO1.1.1
05/06/2023 08:09:10 224 233 XLON 00355210839TRLO1.1.1
05/06/2023 08:07:16 21 233 AQXE 00355210637TRLO1.1.1
05/06/2023 08:05:00 208 233 XLON 00355210439TRLO1.1.1

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSFLFEDRLIEIIV

Talk to a Data Expert

Have a question? We'll get back to you promptly.